Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC Patients
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
A Hierarchical Cytokines Framework Defining Groups of Chronic Inflammatory Diseases: Learning From Cytokine-Targeted TherapiesJune 1, 2014
An Evolving Concept: The Pathologic Level of Brain TNF is a Therapeutic Target for Chronic Pain TreatmentMarch 12, 2018
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC PatientsDecember 21, 2022
Beta2-Adrenergic Agonists for Parkinson’s Disease: Repurposing Drugs at the Crossroad of the Brain and the Immune SystemDecember 2, 2017
Evolutionary Medicine, Energy Regulation and the Pathogenesis of Systemic Chronic Inflammatory DiseasesFebruary 23, 2011
First Evidence That Th22 Cells May Contribute To the Pathogenesis of Graves’ DiseaseSeptember 10, 2014
